These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 17418637

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.
    Reipert A, Ehlert K, Kast T, Bierbaum G.
    Antimicrob Agents Chemother; 2003 Feb; 47(2):568-76. PubMed ID: 12543661
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility.
    Jansen A, Szekat C, Schröder W, Wolz C, Goerke C, Lee JC, Türck M, Bierbaum G.
    BMC Microbiol; 2013 Mar 22; 13():65. PubMed ID: 23522028
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
    Nagel M, Reuter T, Jansen A, Szekat C, Bierbaum G.
    Int J Med Microbiol; 2011 Mar 22; 301(3):229-36. PubMed ID: 21115395
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.
    Berscheid A, François P, Strittmatter A, Gottschalk G, Schrenzel J, Sass P, Bierbaum G.
    J Antimicrob Chemother; 2014 Dec 22; 69(12):3190-8. PubMed ID: 25103491
    [Abstract] [Full Text] [Related]

  • 10. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC.
    Int J Antimicrob Agents; 2007 Nov 22; 30(5):398-408. PubMed ID: 17888634
    [Abstract] [Full Text] [Related]

  • 11. Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains.
    Drummelsmith J, Winstall E, Bergeron MG, Poirier GG, Ouellette M.
    J Proteome Res; 2007 Dec 22; 6(12):4690-702. PubMed ID: 17997515
    [Abstract] [Full Text] [Related]

  • 12. Influence of IS256 on Genome Variability and Formation of Small-Colony Variants in Staphylococcus aureus.
    Kleinert F, Kallies R, Hort M, Zweynert A, Szekat C, Nagel M, Bierbaum G.
    Antimicrob Agents Chemother; 2017 Aug 22; 61(8):. PubMed ID: 28584147
    [Abstract] [Full Text] [Related]

  • 13. Impact of mecA promoter mutations on mecA expression and beta-lactam resistance levels.
    Ender M, McCallum N, Berger-Bächi B.
    Int J Med Microbiol; 2008 Oct 22; 298(7-8):607-17. PubMed ID: 18456552
    [Abstract] [Full Text] [Related]

  • 14. Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.
    McEvoy CR, Tsuji B, Gao W, Seemann T, Porter JL, Doig K, Ngo D, Howden BP, Stinear TP.
    Antimicrob Agents Chemother; 2013 Jul 22; 57(7):3240-9. PubMed ID: 23629723
    [Abstract] [Full Text] [Related]

  • 15. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I, Costa SS, Viveiros M, Martins M, Amaral L.
    J Antimicrob Chemother; 2008 Sep 22; 62(3):504-13. PubMed ID: 18511413
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance.
    Chen H, Xiong Z, Liu K, Li S, Wang R, Wang X, Zhang Y, Wang H.
    Int J Antimicrob Agents; 2016 May 22; 47(5):362-7. PubMed ID: 27084050
    [Abstract] [Full Text] [Related]

  • 17. Increase in IS256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants.
    Di Gregorio S, Fernandez S, Perazzi B, Bello N, Famiglietti A, Mollerach M.
    Infect Genet Evol; 2016 Sep 22; 43():197-202. PubMed ID: 27154328
    [Abstract] [Full Text] [Related]

  • 18. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
    Rose WE, Rybak MJ, Tsuji BT, Kaatz GW, Sakoulas G.
    J Antimicrob Chemother; 2007 Jun 22; 59(6):1190-3. PubMed ID: 17434881
    [Abstract] [Full Text] [Related]

  • 19. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
    Camargo IL, Neoh HM, Cui L, Hiramatsu K.
    Antimicrob Agents Chemother; 2008 Dec 22; 52(12):4289-99. PubMed ID: 18824611
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.